Not sure why people are thinking a Nasdaq listing will even happen in the short term? If the minimum SP needs to be $1 to get listed, then that is at least 1 - 2 years away (12 months is an absolute best case scenario).
For $1 to happen, OVT needs to kick some serious goals. Plus, given the comments by other users on this topic already, the Nasdaq listing will most likely be taken seriously around the $2 -$3 plus range which is ages away imo.
So, given they can't even become listed on the Nasdaq under $1, which is where the SP will be operating for sometime, there's no reason to think this will be happening any time soon, IMO.
US listing can be amazing, check out Sezzle (which they are aware of given it was in the ann) however to maximise the immense value we can get out of a dual listing, we should have a stronger BNPL business first.
Keen for 2025. Keast is building a strong team.
- Forums
- ASX - By Stock
- OVT
- Ann: EAS Advisors Appointed for USA Expansion
OVT
ovanti limited
Add to My Watchlist
12.5%
!
0.7¢

Ann: EAS Advisors Appointed for USA Expansion, page-27
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.7¢ |
Change
-0.001(12.5%) |
Mkt cap ! $21.03M |
Open | High | Low | Value | Volume |
0.9¢ | 1.0¢ | 0.6¢ | $975.6K | 125.8M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
41 | 23311539 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 7019418 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
36 | 20974873 | 0.006 |
43 | 28476199 | 0.005 |
30 | 20433337 | 0.004 |
35 | 47005772 | 0.003 |
76 | 65040338 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 4811085 | 9 |
0.008 | 13474447 | 13 |
0.009 | 30349046 | 23 |
0.010 | 17234151 | 25 |
0.011 | 17600302 | 25 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
OVT (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online